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Background: Bioprosthetics derived from human or porcine dermis and intestinal submu-
cosa have dense, homogenous, aporous collagen structures that potentially limit cellular
penetration, undermining the theoretical benefit of a “natural” collagen scaffold. We hy-
pothesized that Miromeshda novel prosthetic derived from porcine liver by perfusion
decellularizationdprovides a more optimal matrix for tissue ingrowth.
Methods: Thirty rats underwent survival surgery that constituted the creation of a 4  1 cm
abdominal defect and simultaneous bridged repair. Twenty rats were bridged with Miromesh,
and10ratswerebridgedwithnonecross-linkedporcinedermis (Strattice).TenMiromeshandall
10Stratticewere rinsed invancomycin solutionand inoculatedwith104 colony-formingunits of
green fluorescent proteinelabeled Staphylococcus aureus (GFP-SA) after implantation. Ten Mir-
omesh controls were neither soaked nor inoculated. No animals received systemic antibiotics.
All animals were euthanized at 90 d and underwent an examination of their gross appearance
before being sectioned for quantitative bacterial culture and histologic grading. A pathologist
scored specimens (0e4) for cellular infiltration, acute inflammation, chronic inflammation,
granulation tissue, foreign body reaction, and fibrous capsule formation.
Results: All but one rat repaired with Strattice survived until the 90-d euthanization. All
quantitative bacterial cultures for inoculated specimens were negative for GFP-SA. Of nine
Strattice explants, none received a cellular infiltration score >0, consistent with a poor
tissueemesh interface observed grossly. Of 10 Miromesh explants also inoculated with
GFP-SA, seven of 10 demonstrated cellular infiltration with an average score of þ2.7  0.8,
whereas sterile Miromesh implants received an average score of 0.8  1.0. Two inoculated
Miromesh implants demonstrated acute inflammation and infection on histology.
Conclusions: Aprosthetic generated fromporcine liver byperfusiondecellularizationprovides
a matrix for superior cellular infiltration compared with nonecross-linked porcine dermis.
ª 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC
BY license (http://creativecommons.org/licenses/by/4.0/).5 American College of Surgeons Clinical Congress, Chicago, Illinois.
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j o u r n a l o f s u r g i c a l r e s e a r c h 2 0 1 ( 2 0 1 6 ) 2 9e3 7301. Introduction MN)dwith intact remnant portal triadsdwould provide aThe use of prosthetic reinforcement for all but the smallest of
ventral hernia repairs has consistently produced lower
recurrence rates [1e3]. Although synthetic mesh has tradi-
tionally been used in this scenario, concern for chronic
infection or mesh complications associated with use of a
permanent prosthetic is legitimate [4,5]. Biologic mesh was
introduced as an alternative to permanent synthetic mesh
more than 20 y ago. The extracellular matrix proteins retained
after decellularization of human or animal tissue theoretically
provide a “natural” collagen scaffold for tissue ingrowth.
Moreover, collagen remodelingwould potentially turnover the
biologic scaffold so that a permanent materialdsusceptible to
chronic infectiondwould not be retained within the wound.
Soon, the theoretical benefit of biologic mesh in the context of
contaminated or “high risk” wounds increased their popu-
larity [6e8].
Currently, most biologic scaffolds are generated by im-
mersion decellularization, a technique limited to relatively
thin and dense tissues to provide adequate mechanical
properties [7,9e11]. This includes prosthetics derived from
dermis, pericardium, small intestine submucosa, and the
urinary bladder matrix. The relative density and thickness of
some collagen scaffolds appears to be an impediment to
recellularization [12,13]. In addition, multiple groups have
reported that some proprietary decellularization techniques
include the addition of proteases and nucleases. The result of
such treatments is a prosthetic that elicits a foreign body
response and blunted recellularization pattern [14,15].
To address the limitation of immersion-based protocols, a
new technique has been reported: perfusion decellularization
[16e18]. Perfusion decellularization uses a native lumen
(vessel, duct, and so forth) to promptly perfuse a decellula-
rizing solution to an entire organ or tissue. This enables the
use of larger, less dense tissues, although maintaining the
native architecture of the organ associated with successful
recellularization [19e21]. Given the ability to decellularize
whole organs via perfusion decellularization, we hypothe-
sized that a novel biologic prosthetic derived from a whole
porcine liver (Miromesh; Miromatrix Medical Inc, Eden Prairie,Fig. 1 e Study design. CFU [ colony-forming units; GFP-SA [ g
version of figure is available online.)more optimal matrix for tissue ingrowth than a popular
nonecross-linked porcine dermal-based prosthetic.2. Methods
2.1. Design
A total of 30 SpragueeDawley rats underwent survival surgery
with placement of a prosthetic to bridge a defect made in the
rectus muscle. Twenty rats were bridged with Miromesh, and
10 rats were bridged with Strattice. Half of the rats bridged
with Miromesh and all those bridged with Strattice were
rinsed with vancomycin solution (10 mg/mL for 15 min) and
inoculated with 104 colony-forming units (CFU) of green
fluorescent proteinelabeled Staphylococcus aureus (GFP-SA).
Animals were survived for 90 d before euthanization and
explantation of the prosthetic for quantitative bacterial cul-
ture and histologic analysis (Fig. 1).2.2. Animals
The Institutional Animal Care and Use Committee of Case
Western Reserve University approved this study given the
following parameters. Male SpragueeDawley rats (HSD:SD;
Harlan Laboratories, Indianapolis, IN) weighing approxi-
mately 300 g were acclimated for at least 1 wk to their housing
and were provided food and water per protocol. Inhaled
isoflurane was used for operative anesthesia and was sup-
plemented with a subcutaneous injection of marcaine
(5% diluted, 1:10) at the operative site. Subcutaneous in-
jections of buprenorphine and ketorolac were administered
for the first four postoperative days. To prevent dehydration
and acute kidney injury in the context of a nonsteroidal anti-
inflammatory drug during the early postoperative period,
3e5 mL of normal saline solution were administered subcu-
taneously with the pain medications. No animals received
systemic antibiotics. All operations were performed under
sterile conditions.reen fluorescent proteinelabeled Staph aureus. (Color
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Consistent with our previously developed model, rats under-
went survival surgery with development of an acute abdom-
inal defect and simultaneous bridged repair [22,23]. Before the
procedure, the abdomen was clipped and prepped with 70%
chlorhexidine and 70% isopropyl alcohol. After induction of
anesthesia and administration of subcutaneous local anes-
thetic, a 4-cm curvilinear incision was made in the skin to
identify the underlying linea alba. This allowed for a 4 cm
longitudinal midline laparotomy 1 cm below the xiphoid,
followed by sharp removal of 0.5 cm of muscle from each
rectus resulting in a 4  1 cm midline defect. The defect was
then repaired by placing a 5  2 cm prosthetic into the peri-
toneal cavity as a bridged underlay. The prosthetic was
secured to the overlying abdominal musculature with at least
12 interrupted transfascial 0000 (4-0) polypropylene sutures.
The skin was then closed with interrupted 0000 (4-0) poly-
glactin sutures. For GFP-SA inoculated animals, a 25-gauge
needle was placed through the skin above the prosthetic
after skin closure and 100 mL of 105 CFU/mL solution was
injected. Finally, the surgical incision was protected during
the initial postoperative period using a custom jacket if
tolerated, whichwas removed on postoperative day 4. Of note,
all animals in this study underwent survival surgery on the
same day and sterile Miromesh rats were completed first to
prevent crosscontamination.
2.4. Bacteria
A clinical strain (Seattle 1945) of S aureus transformed with
green fluorescent proteinelabeled plasmid to produce SA
1945GFPuvrwas used in this study to confirm clearance of the
delivered bacterial burden inoculum [24]. The strain was
recovered from storage at 70C by subculture onto a tryptic
soy agar plate with 5% sheep blood, whichwas then incubated
at 37C for 24 h. An individual colony was then inoculated in
5 mL of brain heart infusion broth and incubated in a 37C
shaker at 200 rpm for 24 h. A 1:50 dilution of the overnight
bacterial brothwas then created and placed in a 37C shaker at
200 rpm for 2.5 h, allowing the bacteria to reach log-phase
growth at a concentration of 108 CFU/mL based on optical
density. This growth was then serially diluted in sterile 0.9%
normal saline to a concentration of 105 CFU/mL, which was
subsequently used to inoculate the aforementioned speci-
mens. The viability and inoculum concentration of the culture
were verified on the day of the study.
2.5. Necropsy
After a 90-d survival period, the animals were euthanized with
carbon dioxide asphyxiation. The previous abdominal
laparotomy was then opened and the prosthetic excised with
adjacent abdominal wall en bloc. The gross appearance of each
specimen was documented. Adhesions with the abdominal
viscera were divided sharply. A small piece (w1  1 cm) was
removed from the rest of the prosthetic, weighed, and placed in
sterile saline. If there was any concern for infection grossly, the
area of most concern was chosen. The rest of the prosthetic and
adjacent tissue was submerged in 10% buffered formalin.2.6. Quantitative cultures
Sections of prosthetic were homogenized and serial 10-fold
dilutions of the mesh and tissue homogenate were made in
0.9% saline. The original suspension and dilutions were plated
in 100-mL volumes on tryptic soy agar plates with 5% sheep
blood and incubated for 48 h at 37C. Bacterial growth was
quantified from plates showing 30e300 CFU per plate. The
absence of growth on any plate was considered sterile. The
presence of colonies negative for green fluorescence was from
specimens considered to have cleared the initial GFP-SA bac-
terial burden.
2.7. Histologic analysis
After fixation in formalin for at least 72 h, all samples were
paraffin embedded, sectioned (5-mm thickness), and stained
with hematoxylin and eosin and Masson’s trichrome stains.
Each analyzed sample included normal abdominal wall, the
meshetissue interface, and the bridged biomaterial repair.
Histologic sections were done to optimally represent the best
tissueemesh interface apparent on gross examination. At
least three optimal sectionswere taken for each specimen and
prepared. The samples were scored on a scale of 0e4 for the
presence of the following characteristics: degree of cellular
infiltration, acute inflammation, chronic inflammation, gran-
ulation tissue formation, foreign body reaction, and fibrous
capsule formation. Briefly, histology scores were defined as
follows: (1) cellular infiltrationdpresence of monocytes,
macrophages, and fibroblasts in the absence of neutrophils or
lymphocytes to suggest inflammation; (2) acute inflamma-
tiondpresence of neutrophils and mast cells; (3) chronic
inflammationdpresence of mononuclear cells, including
lymphocytes and plasma cells; (4) granulation tissuedpre-
sence of macrophages, fibroblasts, and blood vessel forma-
tion; (5) foreign body reactiondpresence of foreign body giant
cells, monocytes, and macrophages; (6) fibrous capsule
formationdpresence of acellular collagen. Evaluation was
performed using light microscopy at 2.5, 5, and 12.5 times
magnification. Each specimen received a grade on a scale of
0e4 for each histologic characteristic (0 ¼ none, 1 ¼minimal,
2 ¼ mild, 3 ¼ moderate, and 4 ¼ extensive). A single clinical
pathologist experienced in histologic analysis of explanted
biologic materials (J.M.A.) evaluated and scored all specimens
in a blinded fashion.3. Results
Of 30 rats that underwent survival surgery, 29 (97%) survived
until the 90-d euthanization. One rat implanted with
nonecross-linked porcine dermis (Strattice) died within 1 wk
of the initial operation from pneumonia and was excluded
from analysis.
3.1. Gross appearance
Representative photographs of Miromesh and Strattice 90-
d explants are provided in Figure 2. Miromesh samples
demonstrated tissue coverage with omentum, visceral
Fig. 2 e Gross appearance. (A) Miromesh explant with a favorable tissueemesh interface and evidence of neoperitoneum. (B)
Miromesh explant with a poor tissueemesh interface. Note the crimped or curled edges of the prosthetic and the absence of
neoperitoneum. (C) Strattice explant with no gross evidence of tissue ingrowth or neoperitoneum. (Color version of figure is
available online.)
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tissueemesh interface in nine of 10 inoculated specimens and
five of 10 sterile implants (Fig. 2A). The remaining Miromesh
samples had few adhesions, scant tissue coverage, and a
tissueemesh interface only maintained by sutures placed at
the time of implantation (Fig. 2B). Uniformly, Strattice ex-
plants did not demonstrate similar tissue coverage, visceral
adhesions, or the presence of a neoperitoneum. Strattice
samples were mostly secured to adjacent tissue by sutures
placed at the time of the initial survival surgery (Fig. 2C).
Neither prosthetic demonstrated adhesed or fistulized intes-
tine on explantation. There were also no instances of repair
failure at the meshetissue suture line resulting in hernia
“recurrence” or evisceration.
3.2. Microbiological analysis
All quantitative cultures of Miromesh (10/10) and Strattice
(9/9) placed in surgical fields contaminated with 104 CFU of
GFP-SA were negative for fluorescent colonies at 90 d. This
indicates 100% clearance of the initial bacterial burden by both
Miromesh and Strattice.
3.3. Histologic analysis
Regarding cellular infiltration, inoculated Miromesh samples
received an average score of 2.3 1.2. Two inoculated samplesfrom this group demonstrated the presence of infection and
were excluded. One inoculated Miromesh sample that
demonstrated a poor tissueemesh interface on gross exami-
nation also received a cellular infiltration score of 0.When this
sample is excluded, the average score for this group is
2.7  0.8. Miromesh samples placed in sterile surgical fields
had an average cellular infiltration score of 0.8 1.0. No sterile
Miromesh samples demonstrated the presence of infection on
histology. Five sterile Miromesh samples demonstrated a poor
tissueemesh interface on gross examination, and all received
cellular infiltration scores of 0. When these are excluded, the
average cellular infiltration score for this group is 1.6  0.9.
Strattice explants uniformly received a cellular infiltration
score of 0 (see Table). No Strattice explants demonstrated the
presence of infection on histology.
Representative photomicrographs are presented in
Figure 3AeC. Figure 3A and B demonstrates Miromesh in
contaminated and clean surgical field, respectively. Both ex-
amples demonstrate cellular infiltrationwithin the prosthetic,
demarcated at the tissueemesh interface. On the contrary,
Figure 3C depicts Strattice in a contaminated field with no
cellular infiltration beyond the tissueemesh interface.
In regard to the presence of acute inflammation, two
inoculatedMiromesh samples demonstrated scores of 1 and 2,
and these samples were excluded from the analysis of
cellular infiltration because of the presence of infection. The
remaining inoculated Miromesh, sterile Miromesh, and















Miromesh clean 3 0 0 0 2 2
2 0 0 0 2 2
1 0 0 0 2 2
1 0 0 0 2 2
0 0 0 0 0 0
1 0 0 0 1 2
0 0 0 0 1 1
0 0 0 0 1 1
0 0 0 0 1 1
0 0 0 0 0 0
Miromesh GFP-SA 2 0 0 0 1 1
2 0 0 0 1 1
3 0 0 0 2 1
3 0 0 0 2 1
3 0 0 0 2 2
* 2 0 0 0 0
0 0 0 0 0 0
4 0 0 0 2 2
* 1 3 0 2 2
2 0 2 0 2 2
Strattice GFP-SA 0 0 0 0 2 2
0 0 0 0 1 1
0 0 0 0 1 1
0 0 0 0 1 1
0 0 0 0 1 1
0 0 0 0 1 1
0 0 0 0 1 1
0 0 0 0 1 1
0 0 0 0 1 1
GFP-SA ¼ green fluorescent proteinelabeled Staphylococcus aureus.
* Indicates the presences of acute inflammation and infection.
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acute inflammation. Chronic inflammation was also seen in
two inoculated Miromesh samples, including one of the
samples that demonstrated acute inflammation and
infection. The other specimen with chronic inflammation,
however, did not demonstrate acute inflammation or
infection. The remaining samples from all three groups
received chronic inflammation scores of 0.
The remaining categories of histologic analysis were
similar between groups. All specimens from all groups
received a granulation tissue score of 0. Inoculated Miromesh,
sterile Miromesh, and Strattice explants received average
foreign body reaction scores of 1.4  0.8, 1.2  0.8, and
1.1  0.3, respectively. Likewise, these groups received fibrous
capsule scores of 1.2 0.8, 1.3 0.8, and 1.1 0.3, respectively.4. Discussion
Miromesh is a bioprosthetic created by a novel decellularization
technique with the aim of creating a collagen scaffold more
receptive to cellular infiltration. Our in vivo analysis found that a
popular biologic mesh derived from porcine dermis (Strattice)
actuallyhadalmostnomeasurable cellular infiltrationat 90d.On
the contrary, Miromesh demonstrated superior cellular infiltra-
tion with equivalent clearance of a bacterial inoculum.Miromesh is novel in that it is a bioprosthetic derived from
whole-organ perfusion decellularization. Perfusion decellula-
rization efficiently delivers decellularizing agents to an entire
organ via the native vascular tree, as opposed to immersion
and agitation techniques that depend on diffusion of the agent
into the tissue [18]. Although perfusion decellularization is not
essential to generate an intact vascular network, it is certainly
a more efficient and practical means of decellularizing large
organs with an intact extracellular matrix [25]. Tissue such as
dermis and submucosadcommon sources for popular bio-
logic prosthesesddo not have such straightforward vascular
access amendable to perfusion decellularization. Such prod-
ucts generated from dermis have highly dense collagen
matrices that have been shown to impede cellular infiltration
and biointegration [12,13]. Specifically, Strattice has been
shown to retain the dense microscopic architecture and ul-
trastructural features of the native porcine dermis extracel-
lular matrix after proprietary decellularization [26]. The
advantage of perfusion decellularization is the use of less
dense extracellular matrices with remnant lumens to theo-
retically encourage cellular infiltration. Previously, in vitro
recellularization of a decellularized matrix has been shown to
be successful for whole organs [19e21]. Here, we attempted to
show that the presence of remnant portal triads in Miromesh
allowed superior cellular infiltration in vivo when compared
with a popular nonecross-linked dermal-based biologic mesh
Fig. 3 e Photomicrographs. (i) H&E 5 3 1.25. (ii) Trichrome 5 3 1.25. (iii) H&E 10 3 1.25. (iv) Trichrome 5 3 1.25. (A) Miromesh
in the presence of contamination. (B) Miromesh placed in a clean surgical field. (A and B, iii) The prosthetic (Miromesh) is
between the red arrows that mark the tissueemesh interface. Note the degree of cellular infiltration within the prosthetic,
demarcated by the thick black arrows. (A and B, iiieiv) Higher magnification allows visualization of neovascularity, marked
by thin black arrows. The presence of foreign body giant cells are marked by arrow heads. (C) Strattice in the presence of
contamination. (C, iii) Again, red arrowsmark the tissueemesh interface. As indicated in (C, i), the prosthetic is on the top of
the photomicrograph. There is no cellular infiltration to make note of. Higher magnification allows visualization of foreign
body giant cells and neovascularity at the tissueemesh interface. H&E[ hematoxylin and eosin. (Color version of figure is
available online.)
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Fig. 3 e (continued).
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infiltration and appeared grossly inert. Miromesh, placed in
sterile and inoculated surgical fields, demonstrated marked
cellular infiltration based on histology and representative
photomicrographs. A relevant study by Reiffel et al. [27] also
revealed poor cellular ingrowth of Strattice at 14 d in a sub-
cutaneous murine model but acknowledged that a longer end
point is necessary to determine the fate of any biologic scaf-
fold. Our 90-d end point confirms their observation when
addressing this limitation.
As an aside, the aforementioned study by Reiffel et al. quan-
tifies cellular infiltration by nucleated cell counts. Although this
may be viewed as amore objective and precisemeasurement of
infiltration comparedwithour “0e4”measurement system, their
system does not distinguish between cell types. This becomes
important when determining the presence of acute and chronic
infection, as the character of any cellular infiltration may not be
optimal.Thiswillbediscussed later.AnotherstudybyGarcia etal.
[28] uses a similar 0e4 system in regards to the scoring of indi-
vidual cell types when comparing matrix integration between
two biologic grafts in an animal model. Although this method is
more specific, it requires the reader to interpret the cellular
infiltrationpatternanddiscernadiagnosis.Ourpreferencewasto
allow an experienced pathologist (J.M.A.) who specializes in the
evaluation of bioprosthetic explants to synthesize his assess-
ment of thehistologic specimens.Needless to say, theabsenceof
a standardized scoring system and animal model for evaluation
of bioprosthetics is a limitation of all such studies and restricts
comparisons within the literature.
Although Miromesh appears to benefit from the presence
of large remnant lumens as paths for cellular migration,access to these lumens is only met at the periphery of the
mesh. The large bilaminar faces of the Miromesh prosthetic
are a remnant of Glisson’s capsule. Our histologic assessment
of the meshetissue interface at the periphery of the mesh
showed cellular infiltration progress from the periphery to-
ward the middle of the mesh, but minimally through the
broad surface of themesh. As highlighted by the six instances
with cellular infiltration scores of 0, these correlated with a
poor tissueemesh interface at the edge of the mesh. This in-
dicates that cellular infiltration into the wide extracellular
matrix allowed by perfusion decellularization is only as good
as the access to this matrix. Projecting toward the product’s
usage to the clinical realm, this observation suggests that the
product might benefit from placement in a plane with bila-
minar coverage (i.e., preperitoneal or retrorectus space) as
opposed to the underlay technique in our animalmodelwhere
access to the periphery of themesh is potentially inconsistent.
Although the underlay position is likely suboptimal for Mir-
omesh specifically and a limitation of the analysis, we chose
to evaluate the prosthetic using the same methodology used
in our previous studies of biologic and permanent meshes for
consistency [22,23,29,30].
Although the presence of Glisson’s capsule appears to be a
barrier to cellular infiltration on the large bilaminar surface of
the prosthetic, its presence provides strength of the material.
Although cellular infiltration is important, many bio-
prosthetics are used in a context where strength and dura-
bility are paramount until native collagen is present. The large
porosity and less dense native tissue used to generate Mir-
omesh by perfusion decellularization conversely can raise
questions regarding the strength of the tissue. Although
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sion is that the capsule increases the strength of the material.
Interestingly, our previous experience with testing biome-
chanics on biologic mesh indicated that the most common
area of failure was at the tissueemesh interface [30]. Although
the strength of Miromesh will ultimately be measured in
clinical practice, it is reassuring that grossly and histologi-
cally, Miromesh contained a superior tissueemesh interface.
Furthermore, a study by Deeken et al. [31] demonstrated that
the tensile strength of a bioprosthetic alone (without a tissue
interface) was not influenced by cellular infiltration and
neovascularization.
The instances of a poor tissueemesh interface revealed
several observations of Miromesh worth noting. Miromesh,
unlike its dermal or submucosa-based counterparts, has a
heterogeneous makeup. This became relevant when taking
bites of Miromesh with suturedsome bites could be taken
through a large lumen (i.e., remnant portal or haptic vein) and
the tissue edge may fold. Also, some edges were more porous
than others and exposed lumens of various sizes depending
on where the mesh was sectioned relative to its proximity to
the native liver capsule. Although no benefit was appreciated
in regards to large versus small lumens in regards to cellular
ingrowth, this heterogeneity understandably can generate
inconsistent results between specimens. This in conjunction
with the technical issues brought up during implantation by
the prostheticmakeup can account for some of the exceptions
where a good tissueemesh interface was not observed.
Finally, several observations suggest that the presence of a
bacterial inoculum actually promotes cellular infiltration in Mir-
omesh. Specifically, the average cellular infiltration score of
Miromesh samples placed in sterile surgical fields was 0.8  1.0,
and 1.6  0.9 when samples without a good meshetissue inter-
face were removed. Samples placed in contaminated fields,
however, received an average score of 2.3 1.2, which increases
to 2.7 0.8when sampleswith a poor tissueemesh interface are
removed. The initial presence of bacteriawithin themesh lumen
can potentiate an acute inflammatory response within the
prosthetic, which when overcome, leaves a sterile cellular infil-
trate. However, for instances where the acute inflammation
persists, the association of higher cellular infiltration with a
bacterial inoculum could be considered concerning as infection
and colonization of biologic prosthetics have not only been
demonstrated, but have been associated with major clinical
complications [32e34].ArelevantstudybyBellows etal. [35]using
a similar rat model demonstrated that the presence of a higher
bacterial burden of Methicillin-resistant Staphylococcus aureus
(MRSA) decreased the strength of two biologic prosthetics,
although this inconsistently correlated with cellular repopula-
tion and neovascularization. Although Badylak et al. confirmed a
decrease in bioprosthetic strength after implantation in
contaminated fields, increased prosthetic strength associated
withmounting cellular infiltration suggests that thisweakness is
transient [36,37]. The balance between cellular infiltration and
subsequent collagen remodeling versus infection, rapid degra-
dation, and prostheticweakness is delicate. Ourmodel sought to
simulate the presence of contamination in our inoculated spec-
imens,whichactually improved cellular infiltrationofMiromesh
compared with clean controls. The presence of a vancomycin
rinsewas introducedduringpilot studies to counter thepotentialfor acute infection within the lumens of the mesh before sterile
cellular infiltration could be achieved. Still, two contaminated
specimens showed the presence of infection, although the
inoculumwasclearedaccording toourquantitative tissueemesh
cultures.Unfortunately, thedesignofour small-animal studydid
notallowforexplants largeenoughforbiomechanical analysis to
correlate the effect of inoculation on prosthetic strength. Corre-
latingouranimalmodelwithclinical levelsof contaminationand
true risk of chronic infectionor aweakenedprosthetic is difficult,
but readers should be aware of this concern in heavily contami-
nated scenarios.5. Conclusions
Miromeshda novel bioprosthetic generated by perfusion
decellularizationddemonstrated superior cellular infiltration
when compared with a popular nonecross-linked porcine
dermal-based prosthetic. Although clearance of a bacterial
inoculum was equivalent and higher cellular infiltration was
demonstrated in the presence of contamination, the clinical
relevance of this is yet unknown.
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